Jordan Walker, DO
General Practice · Grand Rapids, MINPI 1205570561
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.
Across 36 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$154
- Lilly USA, LLC$150
- AbbVie$129
- Johnson & Johnson$57
- Madrigal Pharmaceuticals$46
- Celltrion USA Inc.$44
- plus $179 from 9 others
What the payments were for
- Food & beverage$760100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $154 |
| Lilly USA, LLC | 6 | $150 |
| AbbVie | 5 | $129 |
| Johnson & Johnson | 2 | $57 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Celltrion USA Inc. | 2 | $44 |
| Biocryst US Sales Co., LLC | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Pfizer | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
How this compares
$760 in reported general payments places this provider in the 75th percentile of 3,051 general practice providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Other general practice in Grand Rapids
- Stefan DylewskiGrand Rapids$19K
- Bryton MansfieldGrand Rapids$14K
- Kelsey SturgisGrand Rapids$9K
- Sara KuckhoffGrand Rapids$8K
- Anil PrasadTaylor$1.7M
- Sadeer DaoodDearborn$1.1M
- Shakib HalabuWest Bloomfield$1.1M
- Christian GrothAnn Arbor$283K
- Dennis FasbinderAnn Arbor$194K
- Kevin BoneSaginaw$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.